Fundraising Fox
/Companies
Sign in

Nectero Medical

Dover, US · Founded 2017 · 6 known investors

Find your way into Nectero Medical

Sign up to see every warm intro you have to Nectero Medical

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Nectero Medical team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Nectero Therapeutics develops therapeutic devices for vascular medicine, working with key opinion leaders in the field. The company operates in the medical device and biotech space.

BiotechHealthtechMedical Devices

Founders & leadership

JSJack Springer
Jack SpringerChief Executive OfficerHe serves as executive chairman of R3 Vascular and managing director at RM Global Partners, and previously held the same chairman role at Capture Vascular and served as a board member and consultant to Vatrix Medical. Earlier in his career he was vice president of commercial operations and brand marketing at Medtronic and president of US operations at INVATEC, and he has run JDS Consulting, a medical devices and diagnostics practice.
BRBruce Roberts
Bruce RobertsNamed on SEC filing

Investors · 6

Aphelion Capitallisted by Aphelion Capital

How we know: Aphelion Capital's portfolio page · Not right? Tell us

Corewell Health Ventureslisted by Corewell Health VenturesGrand Rapids

How we know: Corewell Health Ventures's portfolio page · Not right? Tell us

BioStar CapitalreportedCharlevoix · $250K – $3M

How we know: funding news · Not right? Tell us

Norwest Venture PartnersreportedMenlo Park · $10M – $30M

How we know: funding news · Not right? Tell us

Also in the syndicate · 1

Boston Scientific Corporationlead

Reported raises · per SEC filings

Form D private placements

$51M disclosed across 2 of 3 rounds · 2020–2024

▶$32.8MraisedMay 2024 · 30 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Anil DasuDirector
  • Colin MorrisonDirector
  • Bryan ZieglerExecutive Officer
  • Bruce RobertsDirector
  • Jack SpringerExecutive Officer, Director
  • Robert WhirleyDirector
Offering amount
$96.6M
Amount sold
$32.8M
First sale
Apr 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$18.2MraisedSep 2021 · 31 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • John SpringerExecutive Officer, Director
Offering amount
$18.2M
Amount sold
$18.2M
First sale
Aug 2021
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.5MofferedApr 2020 · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • John SpringerExecutive Officer, Director
  • Bruce RobertsDirector
Offering amount
$1.5M
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Nectero Medical: Revolutionizing the Treatment of Abdominal Aortic Aneurysms - Norwestnorwest.com · Apr 2026

Frequently asked questions

What does Nectero Medical do?
Nectero Therapeutics develops therapeutic devices for vascular medicine, working with key opinion leaders in the field. The company operates in the medical device and biotech space.
Who are Nectero Medical's investors?
Nectero Medical's investors include Alumni Ventures, Aphelion Capital, Corewell Health Ventures, BioStar Capital, Norwest Venture Partners.
How much funding has Nectero Medical raised?
Nectero Medical has disclosed $51M raised across 2 of its 3 known rounds.
Where is Nectero Medical headquartered?
Nectero Medical is headquartered in Dover, US.